Showing results (121-130 of 194) with videos related to
Sort By:
Pageof 20
Plos One|May 8, 2014
Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201)John E McKinnon, Robbie B Mailliard, Susan Swindells, et al.HIV Clinical Trials|August 9, 2013
Pilot study of younger and older HIV-infected adults using traditional and novel functional assessmentsUriel Sandkovsky, Kevin R Robertson, Jane L Meza, et al.Current Protocols|June 10, 2024
Establishment of a Four-Cell In Vitro Blood-Brain Barrier Model With Human Primary Brain CellsJohid R Malik, Ukamaka O Modebelu, Courtney V Fletcher, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2013
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programsAnne F Luetkemeyer, Michelle A Kendall, Mulinda Nyirenda, et al.Human Brain Mapping|November 8, 2014
Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV-infected older adultsTony W Wilson, Elizabeth Heinrichs-Graham, Katherine M Becker, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2023
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First TrimesterAmita Gupta, Michael D Hughes, Jorge Leon Cruz, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2013
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE StudyAnne F Luetkemeyer, Susan L Rosenkranz, Darlene Lu, et al.Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamideJacques Grosset, Deepak Almeida, Paul J Converse, et al.Brain Communications|July 11, 2022
Signatures of somatosensory cortical dysfunction in Alzheimer's disease and HIV-associated neurocognitive disorderChloe C Casagrande, Alex I Wiesman, Mikki Schantell, et al.Cerebral Cortex (New York, N.Y. : 1991)|July 20, 2022
Convergent and divergent oscillatory aberrations during visuospatial processing in HIV-related cognitive impairment and Alzheimer's diseaseChloe E Meehan, Christine M Embury, Alex I Wiesman, et al.Pageof 20